Clinical Trial Update: A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 trial of OPA-15406 Foam for children and infants with atopic dermatitis is planned and currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• OPA-15406 Foam (OPA-15406)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Atopic Dermatitis (AD) | Phase 3 | Status: NOT_YET_RECRUITING